Therapeutic Monitoring of Warfarin: the Appropriate Response Marker

Warfarin is a 4‐hydroxycoumarin anticoagulant drug used for the prevention and management of thromboembolic and vascular diseases. It acts through the inhibition of the vitamin K‐dependent transcarboxylation reactions that convert precursors of clotting factors into their active form. Appropriate us...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of pharmacy and pharmacology 2000-11, Vol.52 (11), p.1405-1410
Hauptverfasser:	COSTA, I. M., SOARES, P. J., AFONSO, M., RATADO, P., LANAO, J. M., FALCÃO, A. C.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aged, 80 and over Anticoagulants - pharmacology Anticoagulants - therapeutic use Biological and medical sciences Biomarkers - analysis Blood. Blood coagulation. Reticuloendothelial system Dose-Response Relationship, Drug Drug Monitoring Factor X - analysis Female Humans Male Medical sciences Middle Aged Pharmacology. Drug treatments Prothrombin - analysis Prothrombin Time Sensitivity and Specificity Thromboembolism - drug therapy Treatment Outcome Vascular Diseases - drug therapy Warfarin - pharmacology Warfarin - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!